Coverage
-
May 24, 2019
A False Claims Act case against former executives of newly bankrupt Aegerion Pharmaceuticals Inc. will likely survive a motion to dismiss, a Boston federal judge said Friday, suggesting the suit can move forward even though the government settled claims against the company and declined to intervene against the executives.
3 other articles on this case.
View all »